Drugs / ION464
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04165486 | Jul 2022 → Sep 2027 expected | multiple system atrophy | Ionis Pharmaceuticals, Inc. | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ION464 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04165486 ↗ |
| Route | Intrathecal | “ION464 will be administered by IT injection.” NCT04165486 ↗ |